Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2026-03-07 @ 3:47 PM
Study NCT ID:
NCT01627327
Status:
COMPLETED
Last Update Posted:
2017-11-09
First Post:
2012-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04-01
Start Date Type:
None
Primary Completion Date:
2012-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-21
First Submit QC Date:
None
Study First Post Date:
2012-06-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-29
Results First Submit QC Date:
None
Results First Post Date:
2013-11-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-06-28
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-10-09
Last Update Post Date:
2017-11-09
Last Update Post Date Type:
ACTUAL